|
|
||||||||
1From the Departments of Genetics and 22Neurology, Childrens Hospital, Boston, Massachusetts; the 2Harvard Medical School, Boston, Massachusetts; the 3Division of Neuro-ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; the 4Department of Ophthalmology, Ankara Güven Hospital, Ankara, Turkey; the 5Department of Ophthalmology, University of Texas Health Science Center, San Antonio, Texas; the 6Department of Ophthalmology, Sligo General Hospital, County Sligo, Ireland; the 7Gene Mapping Lab, Pediatric Hematology Unit, Department of Pediatrics, Hacettepe University Medical Faculty, Ankara, Turkey; the 8Department of Ophthalmology, Geisinger Medical Institute, Danville, Pennsylvania; the 9Departments of Ophthalmology and Neurology and the Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California; the 10Royal Childrens Hospital, Department of Ophthalmology, University of Queensland, Brisbane, Australia; the 11Department of Ophthalmology, University of Leicester, Leicester, United Kingdom; the 12University Eye Clinic, Bonn, Germany; the 13University of Melbourne, Department of Ophthalmology, Royal Victorian Eye and Ear Hospital, Melbourne, Australia; 14Instituto de Otorrinolaringología, San Bernardino, Caracas, Venezuela; the 15Childrens Hospital of Los Angeles, Doheny Eye Institute, University of Southern California, Los Angeles, California; the 16Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; 17Cole Eye Institute, the Cleveland Clinic Foundation, Cleveland, Ohio; 18Dipartimento di Scienze Oftalmologiche, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli "Federico II" Napoli, Italy; the 19JKA Institute of Strabismology and Dr. H. L. Patney Memorial Eye Clinic, Rajkot, India; the 20Department of Ophthalmology, Hospital de Niños "Roberto del Rio," Santiago, Chile; and the 21Department of Ophthalmology, Harvard Medical School and the Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
PURPOSE. Three congenital fibrosis of the extraocular muscles phenotypes (CFEOM13) have been identified. Each represents a specific form of paralytic strabismus characterized by congenital restrictive ophthalmoplegia, often with accompanying ptosis. It has been demonstrated that CFEOM1 results from mutations in KIF21A and CFEOM2 from mutations in PHOX2A. This study was conducted to determine the incidence of KIF21A and PHOX2A mutations among individuals with the third CFEOM phenotype, CFEOM3.
METHODS. All pedigrees and sporadic individuals with CFEOM3 in the authors database were identified, whether the pedigrees were linked or consistent with linkage to the FEOM1, FEOM2, and/or FEOM3 loci was determined, and the appropriate pedigrees and the sporadic individuals were screened for mutations in KIF21A and PHOX2A.
RESULTS. Twelve CFEOM3 pedigrees and 10 CFEOM3 sporadic individuals were identified in the database. The structures of eight of the pedigrees permitted the generation of meaningful linkage data. KIF21A was screened in 17 probands, and mutations were identified in two CFEOM3 pedigrees. One pedigree harbored a novel mutation (2841G
A, M947I) and one harbored the most common and recurrent of the CFEOM1 mutations identified previously (2860C
T, R954W). None of CFEOM3 pedigrees or sporadic individuals harbored mutations in PHOX2A.
CONCLUSIONS. The results demonstrate that KIF21A mutations are a rare cause of CFEOM3 and that KIF21A mutations can be nonpenetrant. Although KIF21A is the first gene to be associated with CFEOM3, the results imply that mutations in the unidentified FEOM3 gene are the more common cause of this phenotype.
This article has been cited by other articles:
![]() |
S. Lu, C. Zhao, K. Zhao, N. Li, and C. Larsson Novel and Recurrent KIF21A Mutations in Congenital Fibrosis of the Extraocular Muscles Type 1 and 3 Arch Ophthalmol, March 1, 2008; 126(3): 388 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Lim, E. C. Engle, and J. L. Demer Abnormalities of the Oculomotor Nerve in Congenital Fibrosis of the Extraocular Muscles and Congenital Oculomotor Palsy Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1601 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Engle Genetic Basis of Congenital Strabismus Arch Ophthalmol, February 1, 2007; 125(2): 189 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. S. Antunes-Foschini, F. S. Ramalho, L. N. Z. Ramalho, and H. E. A. Bicas Increased frequency of activated satellite cells in overacting inferior oblique muscles from humans. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3360 - 3365. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamada, D. G. Hunter, C. Andrews, and E. C. Engle A Novel KIF21A Mutation in a Patient With Congenital Fibrosis of the Extraocular Muscles and Marcus Gunn Jaw-Winking Phenomenon Arch Ophthalmol, September 1, 2005; 123(9): 1254 - 1259. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |